APYX vs MRNA · rev $48.1M vs rev $1.94B
Apyx Medical Inc (APYX) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
APYX currently screens at market cap $179.6M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the APYX and MRNA stock pages for the full models.
Not investment advice.